- Home
- APLT vs MDBH Comparison
APLT vs MDBH Comparison
Compare APLT & MDBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- MDBH
- Stock Information
- Founded
- APLT 2016
- MDBH 1997
- Country
- APLT United States
- MDBH United States
- Employees
- APLT N/A
- MDBH N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- MDBH
- Sector
- APLT Health Care
- MDBH
- Exchange
- APLT Nasdaq
- MDBH Nasdaq
- Market Cap
- APLT 80.3M
- MDBH N/A
- IPO Year
- APLT 2019
- MDBH 2023
- Fundamental
- Price
- APLT $0.52
- MDBH $6.31
- Analyst Decision
- APLT Buy
- MDBH
- Analyst Count
- APLT 7
- MDBH 0
- Target Price
- APLT $6.10
- MDBH N/A
- AVG Volume (30 Days)
- APLT 1.6M
- MDBH 2.8K
- Earning Date
- APLT 05-08-2025
- MDBH 05-12-2025
- Dividend Yield
- APLT N/A
- MDBH N/A
- EPS Growth
- APLT N/A
- MDBH N/A
- EPS
- APLT N/A
- MDBH N/A
- Revenue
- APLT N/A
- MDBH $1,937,885.00
- Revenue This Year
- APLT N/A
- MDBH N/A
- Revenue Next Year
- APLT $2,426.33
- MDBH N/A
- P/E Ratio
- APLT N/A
- MDBH N/A
- Revenue Growth
- APLT N/A
- MDBH N/A
- 52 Week Low
- APLT $0.43
- MDBH $5.78
- 52 Week High
- APLT $10.62
- MDBH $12.00
- Technical
- Relative Strength Index (RSI)
- APLT 43.47
- MDBH 43.61
- Support Level
- APLT $0.52
- MDBH $6.33
- Resistance Level
- APLT $0.62
- MDBH $6.52
- Average True Range (ATR)
- APLT 0.05
- MDBH 0.10
- MACD
- APLT 0.01
- MDBH -0.02
- Stochastic Oscillator
- APLT 23.19
- MDBH 27.12
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.